China

Futu Holdings, parent of Hong Kong-based Futu Securities International, is planning a Nasdaq IPO of up to $300m.

CIMC Vehicles Co is eyeing $500m from a Hong Kong IPO, with plans to launch the listing by the end of the first quarter, according to a source close to the deal.

In this round up, Bank of China’s monthly index shows decreasing onshore funding cost, Value Partners’ flagship fund became MRF-eligible and a quarterly London RMB business report shows that the city still leads the way on offshore RMB trading in Europe.

In this round-up, Chinese president Xi Jinping’s speech at the celebration of China’s reform and opening up offered no concrete promises, the People’s Bank of China reopened the seven-day reverse repo after 36 days of suspension, and China dropped its holding of US government bonds for the fifth consecutive month.

The decision to further postpone the ETF Connect between China and Hong Kong offers an opportunity to improve the mutual recognition of funds (MRF) scheme. In a recent report, Ernst & Young and the Hong Kong Investment Funds Association offered the authorities some suggestions.

Hungary’s latest Panda looks, at least on paper, like a club deal rather than a genuine syndicated bond, with bankers disagreeing on how the deal might have played out in the market.

Chinese property companies are pushing their fund-raising for 2018 to the bitter end – with sometimes surprising results. Cifi Holdings scored with a larger-than-expected $400m bond on Monday, while Redsun Properties Group sold a $200m tap.

Wuhan Financial Holdings Group Co made its dollar market debut on Monday, raising $142m from a three year club-style deal.

Bank of China Group Investment, a Hong Kong-based wholly owned subsidiary of Bank of China, will price a Rmb2bn ($290m) three year note on Tuesday. But some rivals have raised questions about whether the deal is a true funding exercise.

Zhongyu Gas Holding has returned to the offshore loan market for its second borrowing this year, offering a $250m three year facility.

Shanghai Henlius Biotech has joined a growing pipeline of biotechnology firms planning to float in Hong Kong. It wants to list in the first quarter of 2019, said a banker working on the transaction.

Bonds issued by China’s Kangde Xin Composite Material Group plummeted in the secondary market on Monday, losing around a third of their value after rumours of an onshore default.